News > Foreign COVID-19 vaccine makers exempted from local clinical trials, batch testing

Foreign COVID-19 vaccine makers exempted from local clinical trials, batch testing

 

DCGI said the requirement of conducting post approval bridging clinical trials and requirement of testing of every batch of vaccine by the CDL can be exempted, if the vaccine lot/batch is certified and released by National Control Laboratory of country of origin.

This will help global COVID-19 vaccine makers like Pfizer, Moderna and other companies developing vaccines to sell their vaccines in India at almost the same time as they launch it in overseas countries.